Neurohormonal profile of rheumatic patients with significant chronic aortic regurgitation

Author(s)

Guilherme Sobreira Spina ^[1] ; Flávio Tarasoutchi ^[2] ; Roney Orismar Sampaio ^[3] ; Marcelo Luiz Campos Vieira ^[4] ; Célia Strunz ^[5] ; Francisco Rafael Laurindo ^[6] ; Max Grinberg ^[7]

Affiliation

^[1] Universidade de São Paulo. Faculdade de Medicina. Hospital das Clínicas

^[2] Universidade de São Paulo. Faculdade de Medicina. Hospital das Clínicas

^[3] Universidade de São Paulo. Faculdade de Medicina. Hospital das Clínicas

^[4] Universidade de São Paulo. Faculdade de Medicina. Hospital das Clínicas

^[5] Universidade de São Paulo. Faculdade de Medicina. Hospital das Clínicas

^[6] Universidade de São Paulo. Faculdade de Medicina. Hospital das Clínicas

^[7] Universidade de São Paulo. Faculdade de Medicina. Hospital das Clínicas

• Document type: Journal article
• Source: Arquivos Brasileiros de Cardiologia; v. 92, n. 2, p. 150-156, 2009-02-00.

Abstract

BACKGROUND: Neurohormones are involved in the physiopathology of heart failure, but little is known about its behavior in significant chronic aortic regurgitation (AR). We aimed at analyzing the behavior of these mediators in AF. OBJECTIVE: We aimed at analyzing the behavior of these mediators in AF. METHODS: We analyzed 89 patients with AF, whose mean age was 33.6±11.5 years and of whom 84.6% were males, 60% asymptomatic, all with rheumatic etiology. After the clinical and echocardiographic assessment, plasma measurements of tumor necrosis factor (TNF), soluble TNF receptor types I and II (sTNFRI e sTNFRII), interleukin-6 (IL-6), its soluble receptor (sIL6R), endothelin-1 and B-type natriuretic peptide (BNP) were carried out; 12 healthy individuals were used as controls. RESULTS: The mean values of the left ventricle diastolic diameter (LVDD) were 71.9±8.3mm, whereas the mean values of the LV systolic diameter (LVSD) were 50.4±9.3mm. The neurohormonal levels were elevated in patients with AF (TNF 92.65±110.24 pg/mL vs. 1.67±1.21 pg/ml in controls, p<0.001), (IL-6 7.17±7.78pg/ml vs. 0.81±0.38pg/mL in controls, p=0.0001) and TNFRI (894.75±348.87pg/mL vs. 521.42±395.13pg/ml, p=0.007). Except for the BNP levels, symptomatic and asymptomatic patients presented a similar neurohormonal profile. There was a correlation between TNFRII and LVDD (r=-0.329, p=0.038) and LVSD (r=-0.352, p=0.027). BNP levels were significantly higher in symptomatic patients and only in the latter it was possible to establish a correlation between BNP and ventricular diameters. CONCLUSION: Patients with significant chronic AF present high neurohormonal levels, with no correlation with the symptomatic status. The TNFRII and BNP levels could be correlated with ventricular diameters, but only the latter could be correlated with symptoms. (AU)